Skip to main content

. 1986 Jan;79(1):5–14. doi: 10.1177/014107688607900104

The science of clinical neurology.

PMCID: PMC1290137 PMID: 3080598

Images in this article

Figure 1.
on p.5

Figure 2.
on p.6

Figure 3.
on p.6

Figure 4.
on p.7

Figure 5.
on p.7

Figure 6.
on p.7

Figure 7.
on p.7

Figure 8.
on p.7

Figure 9.
on p.7

Figure 10.
on p.9

Figure 11.
on p.10

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984 Aug;16(2):193–208. doi: 10.1002/ana.410160206. [DOI] [PubMed] [Google Scholar]
Bakker E., Hofker M. H., Goor N., Mandel J. L., Wrogemann K., Davies K. E., Kunkel L. M., Willard H. F., Fenton W. A., Sandkuyl L. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet. 1985 Mar 23;1(8430):655–658. doi: 10.1016/s0140-6736(85)91325-x. [DOI] [PubMed] [Google Scholar]
Cambridge G., Stern C. M. The uptake of tritium-labelled carnitine by monolayer cultures of human fetal muscle and its potential as a label in cytotoxicity studies. Clin Exp Immunol. 1981 Apr;44(1):211–219. [PMC free article] [PubMed] [Google Scholar]
Cullen M. J., Fulthorpe J. J. Stages in fibre breakdown in Duchenne muscular dystrophy. An electron-microscopic study. J Neurol Sci. 1975 Feb;24(2):179–200. doi: 10.1016/0022-510x(75)90232-4. [DOI] [PubMed] [Google Scholar]
Engel A. G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984 Aug;16(2):209–215. doi: 10.1002/ana.410160207. [DOI] [PubMed] [Google Scholar]
Humphrey J. H. The value of immunological concepts in medicine. The Croonian Lecture 1981. J R Coll Physicians Lond. 1982 Jul;16(3):141–146. [PMC free article] [PubMed] [Google Scholar]
Langdon N., Welsh K. I., van Dam M., Vaughan R. W., Parkes D. Genetic markers in narcolepsy. Lancet. 1984 Nov 24;2(8413):1178–1180. doi: 10.1016/s0140-6736(84)92742-9. [DOI] [PubMed] [Google Scholar]
Mokri B., Engel A. G. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 1975 Dec;25(12):1111–1120. doi: 10.1212/wnl.25.12.1111. [DOI] [PubMed] [Google Scholar]
Rowe D. J., Isenberg D. A., McDougall J., Beverley P. C. Characterization of polymyositis infiltrates using monoclonal antibodies to human leucocyte antigens. Clin Exp Immunol. 1981 Aug;45(2):290–298. [PMC free article] [PubMed] [Google Scholar]
Saunders M., Knowles M., Currie S. Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):569–571. doi: 10.1136/jnnp.32.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schurr P. H. Outline of the history of the Section of Neurology of the Royal Society of Medicine. J R Soc Med. 1985 Feb;78(2):146–148. doi: 10.1177/014107688507800215. [DOI] [PMC free article] [PubMed] [Google Scholar]
Weiner H. L., Hauser S. L. Neuroimmunology I: Immunoregulation in neurological disease. Ann Neurol. 1982 May;11(5):437–449. doi: 10.1002/ana.410110502. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES